Experimental, acute renal hypertension and exogenous angiotensin Ii administration following premedication with the prostaglandin biosynthesis inhibitor indometacin
Schölkens, B.A.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 285-288
1974
ISSN/ISBN: 0070-4067 PMID: 4375905 Document Number: 71483
Document emailed within 1 workday
Related Documents
Pals, D.T.; Fulton, R.W. 1973: Mechanism of the antihypertensive effect of 1-Sar-8-Ala-angiotensin Ii during the acute phase of experimental renal hypertension Archives Internationales de Pharmacodynamie et de Therapie 204(1): 20-30Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Svarstad, E.; Hultstrøm, D.; Jensen, D.; Jenssen, G.; Gravendeel, J.; Iversen, B.M. 2001: Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(15): 1784-1788
Czekanowski, R.; Kuźniar, B. 1985: Analysis of the correlation between the dose-response curve for prostaglandin F2alpha and the progress of pregnancy, cervix ripening, pharmacologic estrogen premedication and Partusisten administration in prostaglandin-induced labor Zentralblatt für Gynakologie 107(2): 79-83
Shimkovich, M.V.; Pshennikova, M.G. 1986: Effect of preliminary administration of prostaglandin E2 and the prostaglandin synthesis inhibitor indomethacin on disturbances of myocardial contraction during stress Biulleten' Eksperimental'noi Biologii i Meditsiny 101(5): 536-537
Nekrasova, A.A.; Serebrovskaia, I.A.; Lantsberg, L.A.; Uchitel', I.A. 1970: Depressor prostaglandin-like substances and renin in the kidneys in experimental renal hypertension Kardiologiia 10(6): 31-36
Abe, K.; Yasujima, M.; Chiba, S.; Sato, M.; Irokawa, N.; Imai, Y.; Yoshinaga, K. 1979: Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system Advances in Experimental Medicine and Biology 120b: 487-501
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Hall, J.E.; Guyton, A.C.; Salgado, H.C.; McCaa, R.E.; Balfe, J.W. 1978: Renal hemodynamics in acute and chronic angiotensin II hypertension American Journal of Physiology 235(3): F174-F179
Fujimoto, S. 1985: Choroidal circulation in experimental hypertension. I. Choroidal blood flow in acute hypertension induced with angiotensin II Nippon Ganka Gakkai Zasshi 89(11): 1242-1250
Gulati, O.P.; Chakravarti, R.N.; Sharma, P.L. 1974: Serial study of plasma angiotensin, electrolytes and juxta-glomerular index in experimental renal hypertension of monkeys Indian Journal of Medical Research 62(1): 86-92
De Clerck, F.; Vermylen, J.; Reneman, R. 1975: Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. in vitro experiments Archives Internationales de Pharmacodynamie et de Therapie 216(2): 263-279
Wakayama, T.; Itoh, T.; Shibayama, K.; Idezuki, Y. 1989: Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs American Journal of Gastroenterology 84(3): 272-278
Antelava, N.A.; Gongadze, N.V.; Gogolauri, M.I.; Kezeli, T.D.; Pachkoriia, K.Z. 2007: Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin Ii receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150: 57-60
Paradowski, A.; Miazgowski, T.; Ogonowski, J.; Cretti, A. 1983: The effect of prostaglandin synthetase inhibitor on pressor reaction during intravenous infusion of angiotensin II in pregnant rabbits Ginekologia Polska 54(7): 445-451
Mangino, M.J.; Brunt, E.M.; Von Doersten, P.; Anderson, C.B. 1989: Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection Journal of Pharmacology and Experimental Therapeutics 248(1): 23-28
Recordati, G.; Zorzoli, F.; Zanchetti, A. 2000: Effects of a reversible 'nephrectomy' on renal sympathetic activity and blood pressure in the rat: evidence for an acute angiotensin-mediated hypertension Journal of Hypertension 18(9): 1277-1287
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
Sharkovska, Y.; Kalk, P.; Karoline von Websky; Relle, K.; Pfab, T.; Alter, M.; Fischer, Y.; Hocher, B. 2011: Renoprotective Effects of Combined Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 in Acute and Chronic Experimental Renal Damage Clinical Laboratory 57(7-8): 507-515
Fedorova, I.B.; Nekliudova, L.I. 1975: Distribution of exogenous interferon in experimental animals following intratracheal administration Voprosy Virusologii 4: 416-418